Comprehensive allelotyping of human intrahepatic cholangiocarcinoma

Area of Science:

• Genetics
• Oncology
• Genomics

Background:

• Intrahepatic cholangiocarcinoma (ICC) is a primary liver cancer with poor prognosis.
• Understanding the genetic alterations in ICC is crucial for identifying therapeutic targets and understanding carcinogenesis.

Purpose of the Study:

• To perform a genome-wide scan for loss of heterozygosity (LOH) in intrahepatic cholangiocarcinoma (ICC).
• To identify specific chromosomal regions and loci frequently affected by LOH in ICC.
• To compare LOH patterns in ICC with those previously observed in hepatocellular carcinoma (HCC) and correlate LOH with clinicopathological features.

Main Methods:

• Genome-wide scan for LOH in 22 ICC cases.
• Utilized 168 polymorphic microsatellite markers across all human chromosomes.
• Included 48 markers previously associated with LOH in hepatocellular carcinoma (HCC).

Main Results:

• Identified 21 loci with LOH in over 30% of informative ICC cases.
• Observed shared high frequencies of LOH with HCC at markers on chromosomes 4q, 6q, 9q, 16q, and 17p.
• Found significantly higher LOH frequency in mass-forming tumors, larger tumors, multiple tumors, and advanced TNM stages (p < 0.01).
• Frequent LOH on 1p36, including the p73 locus, was noted in large tumors without lymph node metastasis.

Conclusions:

• ICC shares common carcinogenic steps with HCC, indicated by shared LOH on chromosomes 4q and 6q.
• Inactivation of tumor suppressor genes on chromosome 1p36 contributes to ICC progression.
• LOH on 1p36 does not appear to be associated with metastatic traits in ICC.